Physician profile
Kevin Short
NPI 1053673897
$1,171.02
in general payments reported to CMS, 2019-2025
9 companies · $385 in 2025
The $385 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.91 · 2020: $28.06 · 2021: $139 · 2023: $412 · 2024: $167 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $963.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $410.97 | 2021-2023 | Augment Injectable, Phalinx, Ortholoc 2 Lapifuse |
| Smith+Nephew, INC. | $384.63 | 2025 | Grafix Pl, Stravix Pl, Oasis Micro |
| Organogenesis INC. | $118.92 | 2024 | |
| Averitas Pharma INC. | $115.92 | 2023 | Qutenza |
| Abbvie INC. | $49.91 | 2023-2024 | Dalvance |
| Djo, LLC | $29.08 | 2019 | |
| Zyla Life Sciences, INC. | $28.06 | 2020 | |
| Convatec INC. | $22.70 | 2024 | |
| Integra Lifesciences Corporation | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Short listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.